We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
MHRA updates guidance for healthcare professionals.
Professor Sir Michael Rawlins, MHRA chair, honoured in the 2017 Queen's Birthday Honours List.
The Queen’s Birthday Honours lists 2017 recognise the achievements of a wide range of extraordinary people from across the UK.
A new e-learning module on the importance of reporting suspected side effects to medicines has received European accreditation.
People and organisations should check public access defibrillators for a technical fault, the Medicines and Healthcare products Regulatory Agency advised today.
The Loughborough University based National Centre for Sport and Exercise Medicine is collaborating with Headley Court’s Academic Department of Military Rehabilitation (ADMR) on a major project that could help UK military per…
Paying for medicines licences, clinical trials and clinical investigations is changing from 1 April the Medicines and Healthcare products Regulatory Agency (MHRA) announced.
A husband and wife from Bootle have today been sentenced at Liverpool Crown Court for the illegal online sale of unlicensed slimming pills.
New online system, Report Illicit Drug Reaction, launched today to improve knowledge of the harmful effects of new psychoactive substances.
Online retailers must follow UK law, as well as the law of the country to which they are selling medicines
The Medicines and Healthcare products Regulatory Agency has launched its latest guide of UK pharmaceutical regulations, EU directives and guidance.…
The UK Stem Cell Bank (UKSCB) at the National Institute for Biological Standards and Control (NIBSC) is releasing its first stem cell lines suitable for development into novel cell-based medicines to researchers wishing to b…
Investigation by the Medicines and Healthcare products Regulatory Agency (MHRA) results in guilty pleas for supplying unlicensed, and potentially dangerous, medicinal products.…
New Years warning issued urging athletes to avoid potentially dangerous DMAA, otherwise known as Methylhexanamine
MHRA has launched a ‘Week of Action’ to improve awareness of unlicensed medicines containing the potentially dangerous ingredient DMAA.
The 2017 New Year Honours recognise the achievements of a wide range of people throughout the health and social care sector.
Looking back at what the Medicines and Healthcare products Regulatory Agency has achieved over the last year.
The Medicines and Healthcare products Regulatory Agency has issued an opinion on the regulatory status of products containing CBD…
The Medicines and Healthcare products Regulatory Agency (MHRA) is conducting a large scale investigation into the diversion of prescription only medicines to the criminal market
The Medicines and Healthcare products Regulatory Agency (MHRA) and the Human Tissue Authority (HTA) have today signed a partnership agreement.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).